Extendicare Inc. (TSE:EXE – Get Free Report) announced a monthly dividend on Friday, October 30th. Investors of record on Monday, November 16th will be given a dividend of $0.0441 per share on Monday, November 16th. This represents a $0.53 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date is Friday, October 30th.
Extendicare Price Performance
Extendicare stock opened at C$26.90 on Wednesday. The business’s fifty day moving average is C$29.57 and its two-hundred day moving average is C$29.82. The company has a debt-to-equity ratio of 159.54, a quick ratio of 0.98 and a current ratio of 0.75. The firm has a market cap of C$2.56 billion, a P/E ratio of 20.60 and a beta of 1.39. Extendicare has a 52 week low of C$15.64 and a 52 week high of C$39.14.
Extendicare (TSE:EXE – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported C$0.38 earnings per share for the quarter. Extendicare had a return on equity of 36.33% and a net margin of 6.13%. The company had revenue of C$611.04 million during the quarter. Equities research analysts forecast that Extendicare will post 0.61 earnings per share for the current fiscal year.
Extendicare Company Profile
Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors’ population, inspired by our mission to provide people with the care they need, wherever they call home. We deliver more than 27 million hours of home health care services annually, operate a network of 97 long-term care homes (58 owned, 39 under management contracts), and provide group purchasing services to third parties representing approximately 161,700 beds across Canada.
Further Reading
- Five stocks we like better than Extendicare
- Hidden in Plain Sight: 2 Earnings Winners Investors May Have Missed
- These 3 New ETFs Are Turning Heads—Are They Worth Buying?
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
